Medicare Prescription Drug Modernization Act Research Paper by hicaliber

Medicare Prescription Drug Modernization Act
A discussion regarding the role of the pharmaceutical lobby in the passage of the Medicare Prescription Drug Modernization Act.
# 95151 | 2,740 words | 7 sources | APA | 2006 | US

$19.95 Buy and instantly download this paper now


This paper takes a look at the success of the Medicare Prescription Drug Modernization Act. According to this paper, the US Government claims that it is a vital source for the elderly and disabled Americans. The paper further discusses how many critics have become doubtful about who actually gains from this act. This paper evaluates dynamics of the relationship between the Pharmaceutical lobby and Congress by revealing how this lobby manages to persuade the decision making in Washington.

Statement of the Problem
Literature Review
Research Design
Limitations of the Research
Validity and Reliability of the Results

Sample of Sources Used:

  • Angell, M. (2004). The Truth about the Drug Companies: How They Deceive Us and What to Do about It. New York: Random House.
  • Guyer, J and Schneider, A. (2004). Implications of the New Medicare Law for Dual Eligibles: 10 Key Questions and Answers. Kaiser Family Foundation.
  • Gross, D. Schondelmeyer, S.W. and Raetzman, S. (2005). Trends in Manufacturer List Prices of Generic Prescription Drugs Used by Older Americans. AARP Public Policy Institute.
  • Ismail, A.M. (2005). Drug Lobby Second to None: How the Pharmaceutical Industry Gets Its Way in Washington. Center for Public Integrity.
  • Kanavos, P. Gross, D. and Taylor, D. (2005). Parallel Trading in Medicines: Europe's Experience and Its Implications for Commercial Drug Importation in the United States. AARP Public Policy Institute

Cite this Research Paper:

APA Format

Medicare Prescription Drug Modernization Act (2007, May 17) Retrieved April 21, 2024, from

MLA Format

"Medicare Prescription Drug Modernization Act" 17 May 2007. Web. 21 April. 2024. <>